Self-Care Education for Joint Stiffness and Functional Ability in Rheumatoid Arthritis
Effectiveness of a Self-Care Educational Program on Joint Stiffness and Functional Ability in Patients With Rheumatoid Arthritis
Rheumatoid arthritis is a chronic inflammatory autoimmune disease that may cause joint stiffness, pain, reduced mobility, and impaired functional ability. Self-care education may help patients improve their knowledge and practices related to disease management, joint protection, physical activity, exercise, energy conservation, and symptom management.
This study aims to evaluate the effectiveness of a self-care educational program on joint stiffness and functional ability among patients with rheumatoid arthritis. Participants will be assigned to either a study group or a control group. The study group will receive the self-care educational program in addition to routine care, while the control group will receive routine care only. Joint stiffness and functional ability will be assessed before and after implementation of the educational program.
調査の概要
状態
条件
詳細な説明
Rheumatoid arthritis is associated with joint inflammation, stiffness, pain, reduced physical functioning, and limitations in activities of daily living. Appropriate self-care practices may contribute to improving patients' ability to manage symptoms and maintain functional independence.
The self-care educational program will provide patients with information and practical guidance regarding rheumatoid arthritis and its management. The program may include disease-related knowledge, medication adherence, joint protection techniques, exercise, energy conservation, activity modification, symptom management, and appropriate self-care practices.
Participants will be divided into two groups:
Study Group: Participants will receive the self-care educational program in addition to routine care.
Control Group: Participants will receive routine care only. Joint stiffness and functional ability will be assessed at baseline and after implementation of the educational program. The outcomes of the study group will be compared with those of the control group to determine the effectiveness of the program.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：REZK A Mohammed, MSc
- 電話番号：1122883312 20+
- メール：RizkAbdullah@nursing.aswu.edu.eg
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- The criteria for selection were: patients" age ranged between 20-65 years old; did not have any auditory, visual or psychological problems. Patients who are able to communicate and participate in the educational program.
Patients who agree to participate in the study.
Exclusion Criteria:
- Patients with severe cognitive or communication impairment. Patients with other severe musculoskeletal conditions that may affect functional ability.
Patients who have participated in a similar self-care educational program recently.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Self-Care Education Group
Participants in the intervention group will receive a self-care educational program designed to improve self-care practices, reduce joint stiffness, and improve functional ability in patients with rheumatoid arthritis.
The program will include education about rheumatoid arthritis, joint protection techniques, appropriate exercises, medication use, and self-care practices.
|
study group Participants will receive the self-care educational program in addition to usual care.
|
|
他の：Routine Care Group
Participants will receive usual care without the self-care educational program.
|
The control group will receive the routine care provided to patients with rheumatoid arthritis and will not receive the self-care educational program during the study period.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
change in joint stiffness
時間枠：Baseline and 3 months after completion of the intervention.
|
Duration of morning joint stiffness will be assessed using a single-item patient-reported outcome measure. Participants will report the duration of their morning joint stiffness in minutes. Durations greater than 12 hours (720 minutes) will be recorded as 720 minutes. Higher values indicate a longer duration of morning joint stiffness. Severity of morning joint stiffness will be assessed using a single-item patient-reported outcome measure. Participants will rate the overall severity of their morning joint stiffness on a numerical rating scale ranging from 0 to 10, where 0 indicates no joint stiffness and 10 indicates the worst possible joint stiffness. Higher scores indicate greater severity of joint stiffness. |
Baseline and 3 months after completion of the intervention.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
functional ability
時間枠：Baseline and 3 months after completion of the intervention.
|
Functional ability will be assessed using the Health Assessment Questionnaire-Disability Index (HAQ-DI).
The HAQ-DI assesses functional ability across eight areas: dressing and grooming, arising, eating, walking, hygiene, reach, grip, and activities.
Each item is scored from 0 (without any difficulty) to 3 (unable to do).
The overall score ranges from 0 to 3, with 0 indicating no disability and 3 indicating severe disability.
Higher scores indicate worse functional ability and greater disability.
|
Baseline and 3 months after completion of the intervention.
|
協力者と研究者
スポンサー
出版物と役立つリンク
一般刊行物
- Seyam, M. H., Boghdady, E. S. G., Abo El-Ata, A. B., & Mahdy, N. E. S. (2024). Knowledge, Practices and Self-Care Management Behaviors for Rheumatoid Arthritis Patients. Port Said Scientific Journal of Nursing, 11(3), 48-68.
便利なリンク
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 1120261455
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。